(0.02%) 5 207.50 points
(0.04%) 39 012 points
(-0.05%) 18 186 points
(0.19%) $78.63
(-1.46%) $2.16
(-0.01%) $2 330.90
(-0.11%) $27.59
(0.73%) $971.95
(0.05%) $0.929
(0.28%) $10.85
(0.07%) $0.797
(0.03%) $91.37
-3.06% $ 0.704
Live Chart Being Loaded With Signals
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 29 418.00 |
Średni wolumen | 58 048.00 |
Kapitalizacja rynkowa | 4.83M |
EPS | $0 ( 2024-03-21 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.390 |
ATR14 | $0.0120 (1.71%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-19 | Ault Milton C Iii | Buy | 1 000 | Common Stock |
2024-04-01 | Ault Milton C Iii | Buy | 334 | Common Stock |
2024-01-05 | Ault Milton C Iii | Buy | 2 000 | Common Stock |
2024-03-26 | Ault Milton C Iii | Buy | 780 000 | Warrants |
2024-03-26 | Ault Milton C Iii | Buy | 780 | Series B Convertible Preferred Stock |
INSIDER POWER |
---|
-10.07 |
Last 96 transactions |
Buy: 11 786 230 | Sell: 5 921 131 |
Alzamend Neuro, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SEDG | 0.983 |
IMUX | 0.974 |
CFRX | 0.973 |
RIDE | 0.973 |
BXRX | 0.971 |
ELEV | 0.97 |
BNGO | 0.969 |
IRDM | 0.968 |
FNCH | 0.967 |
RELI | 0.967 |
10 Najbardziej negatywne korelacje | |
---|---|
ADAL | -0.973 |
SLMBP | -0.973 |
HCNE | -0.971 |
VMGA | -0.97 |
JUGG | -0.967 |
IXAQ | -0.966 |
HORI | -0.966 |
GPAC | -0.966 |
LCAA | -0.964 |
IBEX | -0.962 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Alzamend Neuro, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-23 066.00 (0.00 %) |
EPS: | $-2.29 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-23 066.00 (0.00 %) |
EPS: | $-2.29 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-2.09 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.0594 |
Financial Reports:
No articles found.
Alzamend Neuro, Inc.
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and AL002 that completed preclinical stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej